揭开类风湿性关节炎治疗的荷尔蒙方法及其补充干预措施
Priya Sharad Waghmare1, Deepika Kaushik2, Emel Oz3
1Department of Food Technology and Nutrition, Lovely Professional University, Phagwara, Punjab, 144411, India.
Inflammopharmacology
|January 3, 2025
概括
这项研究探讨了激素和免疫细胞如何影响类风湿性关节炎 (RA). 诸如激素替代疗法 (HRT) 和选择性雌激素受体调节剂 (SERM) 等治疗方法在治疗 RA 症状和改善关节健康方面表现有前途.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 类风湿病学 类风湿病学
背景情况:
- 风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,导致关节炎症,疼痛和骨质退化.
- 免疫细胞 (树突细胞,T细胞,B细胞,巨细胞,中性粒细胞) 和细胞因子 (TNF-α,IL-17A) 是 RA 发病的关键.
- 孕激素和雌激素等激素显著影响RA的免疫系统参与和疾病进展.
研究的目的:
- 研究激素因素和特定免疫调节剂在类风湿性关节炎中的作用.
- 评估与激素相关的治疗对RA治疗的治疗潜力.
主要方法:
- 审查现有关于激素对RA的影响的研究.
- 对激素替代疗法 (HRT) 对 RA 的影响进行分析.
- 选择性雌激素受体调节剂 (SERM) 和淋巴激素释放激素 (GnRH) 治疗在 RA 的背景下进行的检查.
主要成果:
- 激素替代疗法 (HRT) 显示出降低炎症,改善疾病活性,增强关节健康和骨强度的潜力.
- 选择性雌激素受体调节剂 (SERM),如他莫西芬和拉洛西芬,在治疗慢性炎症疾病,包括RA方面表现出有效性.
- 淋巴激素释放激素 (GnRH) 治疗会影响下丘脑-垂体-淋巴腺轴,影响RA活性.
结论:
- 激素疗法和向调节剂为风湿性关节炎提供了有前途的替代治疗策略.
- 这些方法可以改善患者的福祉,并缓解与RA相关的关节疼痛.
- 对激素和免疫调节治疗的进一步研究可能会导致更有效的RA治疗.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
110
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
110
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
Autoimmune Disorders
385
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
385
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
114
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
114


